A Rapid, Isothermal, and Point-of-Care System for COVID-19 Diagnostics.


Journal

Journal of biomolecular techniques : JBT
ISSN: 1943-4731
Titre abrégé: J Biomol Tech
Pays: United States
ID NLM: 100888641

Informations de publication

Date de publication:
09 2021
Historique:
entrez: 9 2 2022
pubmed: 10 2 2022
medline: 12 2 2022
Statut: ppublish

Résumé

The COVID-19 pandemic has had a profound, detrimental effect on economies and societies worldwide. Where the pandemic has been controlled, extremely high rates of diagnostic testing for the SARS-CoV-2 virus have proven critical, enabling isolation of cases and contact tracing. Recently, diagnostic testing has been supplemented with wastewater measures to evaluate the degree to which communities have infections. Whereas much testing has been done through traditional, centralized, clinical, or environmental laboratory methods, point-of-care testing has proven successful in reducing time to result. As the pandemic progresses and becomes more broadly distributed, further decentralization of diagnostic testing will be helpful to mitigate its spread. This will be particularly both challenging and critical in settings with limited resources due to lack of medical infrastructure and expertise as well as requirements to return results quickly. In this article, we validate the tiny isothermal nucleic acid quantification system (TINY) and a novel loop-mediated isothermal amplification (LAMP)-based assay for the point-of-care diagnosis of SARS-CoV-2 infection in humans and also for in-the-field, point-of-collection surveillance of wastewater. The TINY system is portable and designed for use in settings with limited resources. It can be powered by electrical, solar, or thermal energy and is robust against interruptions in services. These applied testing examples demonstrate that this novel detection platform is a simpler procedure than reverse-transcription quantitative polymerase chain reaction, and moreover, this TINY instrument and LAMP assay combination has the potential to effectively provide both point-of-care diagnosis of individuals and point-of-collection environmental surveillance using wastewater.

Identifiants

pubmed: 35136383
doi: 10.7171/jbt.21-3203-019
pii: 20213203019
pmc: PMC8802758
doi:

Substances chimiques

RNA, Viral 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

221-227

Subventions

Organisme : NIDA NIH HHS
ID : U01 DA053941
Pays : United States
Organisme : NCI NIH HHS
ID : UH2 CA202723
Pays : United States
Organisme : NIBIB NIH HHS
ID : R21 EB031466
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI151059
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM138152
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000457
Pays : United States

Informations de copyright

© 2021 ABRF.

Références

Lancet. 2018 Mar 31;391(10127):1285-1300
pubmed: 29248255
Nat Biomed Eng. 2018 Sep;2(9):657-665
pubmed: 30906647
Sci Total Environ. 2021 Dec 1;798:149177
pubmed: 34375259
Environ Sci Technol Lett. 2020 May 20;7(7):511-516
pubmed: 37566285
J Clin Med. 2020 Feb 17;9(2):
pubmed: 32079150
J Autoimmun. 2020 May;109:102433
pubmed: 32113704
Biosens Bioelectron. 2019 May 1;132:17-37
pubmed: 30851493
J Travel Med. 2020 Mar 13;27(2):
pubmed: 32052846
Lancet Infect Dis. 2014 Mar;14(3):239-49
pubmed: 24332389
Euro Surveill. 2020 Mar;25(10):
pubmed: 32183930
JAMA. 2020 Apr 14;323(14):1406-1407
pubmed: 32083643
Lancet Infect Dis. 2020 Jun;20(6):669-677
pubmed: 32240634
Nat Biotechnol. 2020 Sep;38(9):1021-1024
pubmed: 32820257
Nat Commun. 2021 Mar 12;12(1):1660
pubmed: 33712587
BMJ. 2020 Mar 17;368:m1066
pubmed: 32184233
Annu Rev Biomed Eng. 2008;10:107-44
pubmed: 18358075
Virol Sin. 2020 Jun;35(3):344-347
pubmed: 32239445
Nat Rev Microbiol. 2019 Mar;17(3):181-192
pubmed: 30531947
J Clin Microbiol. 2017 Aug;55(8):2313-2320
pubmed: 28539345
Sci Total Environ. 2020 Sep 20;736:139652
pubmed: 32464333
Ann Intern Med. 2020 May 05;172(9):577-582
pubmed: 32150748
Sci Total Environ. 2020 Aug 1;728:138764
pubmed: 32387778
Nat Commun. 2016 Feb 02;7:10164
pubmed: 26836631
N Engl J Med. 2020 Mar 5;382(10):970-971
pubmed: 32003551
Clin Microbiol Rev. 2011 Apr;24(2):314-50
pubmed: 21482728

Auteurs

Christopher Mozsary (C)

Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York, USA.

Duncan McCloskey (D)

Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, USA.

Kristina M Babler (KM)

Department of Civil, Architectural, and Environmental Engineering, University of Miami, Coral Gables, Florida, USA.

Juan Boza (J)

Meinig School of Biomedical Engineering, Cornell University, Ithaca, New York, USA.

Daniel Butler (D)

Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York, USA.

Benjamin Currall (B)

Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida USA.

Sion Williams (S)

Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida USA.

Anne Wiley (A)

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA.

Evan E Afshin (EE)

Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York, USA.

George S Grills (GS)

Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida USA.

Mark E Sharkey (ME)

Department of Medicine, University of Miami Miller School of Medicine, Miami, Florida USA.

Prem Premsrirut (P)

Mirimus, Brooklyn, New York, USA.

Helena Solo-Gabriele (H)

Department of Civil, Architectural, and Environmental Engineering, University of Miami, Coral Gables, Florida, USA.

Yoslayma Cardentey (Y)

Sylvester Comprehensive Cancer Center, Miller School of Medicine, University of Miami, Miami, Florida USA.

David Erickson (D)

Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, New York, USA.
Division of Nutritional Sciences, Cornell University, Ithaca, New York, USA.

Christopher E Mason (CE)

Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH